Landmark, third-party research strengthens evidence of long-term impact beyond a single Girls on the Run season. CHARLOTTE, NC, UNITED STATES, March 25, 2026 ...

Mayor Zohran Mamdani’s drive to expand “free” (city-run, taxpayer-funded) preschool programs is already squeezing private-sector providers, suggesting this “transformation” is more about a government ...

President Donald Trump speaks before signing an executive order on fraud in the Oval Office at the White House in Washington, D.C., on March 16, 2026, as Vice President JD Vance looks on. (Photo by ...

In 2021, Arizona softball had nine run-rule victories in 10 games. The one that kept them from going 10 straight was an extra-inning affair against Oregon State. That kept the program record for ...

CHARLESTON — A nonprofit run by City Councilman Aaron Polkey, who was sworn in last month, is set to receive nearly $240,000 from the city for a homeless program. Polkey, president and CEO of Palmetto ...

James Ratcliff joined GameRant in 2022 as a Gaming News Writer. In 2023, James was offered a chance to become an occasional feature writer for different games and then a Senior Author in 2025. He is a ...

When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...

Social Security, which provides benefits to about 70 million Americans, could run out of money sooner than expected, according to a new report from the Congressional Budget Office. The Old-Age and ...

TURKU, Finland, Feb. 10, 2026 /PRNewswire/ -- Vaadin, the leading provider of Java web application frameworks, today announced the general availability of Swing Modernization Toolkit, a solution that ...

Fullerton has launched its new city-operated ambulance transportation program. Under the model, fire personnel will manage the full emergency response, from initial patient contact to transport to a ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.